Pulse Biosciences Inc IPO év
Mi az Pulse Biosciences Inc IPO év?
A IPO év az Pulse Biosciences Inc - 2016
Mi a IPO év meghatározása?
A kezdeti nyilvános ajánlattétel olyan nyilvános ajánlattétel, amelyben a társaság részvényeit általában olyan intézményi befektetőknek adják el, akik viszont értékpapírcserében először értékesítik a nagyközönségnek.
Through IPO a privately held company transforms into a public company. Initial public offerings are mostly used by companies to raise the expansion of capital, possibly to monetize the investments of early private investors, and to become publicly traded enterprises. A company selling shares is never required to repay the capital to its public investors. After the IPO, when shares trade freely in the open market, money passes between public investors.
Although IPO offers many advantages, there are also significant disadvantages, chief among these are the costs associated with the process and the requirement to disclose certain information that could prove helpful to competitors.
The IPO process is colloquially known as going public. Details of the proposed offering are disclosed to potential purchasers in the form of a lengthy document known as a prospectus. Most companies undertake an IPO with the assistance of an investment banking firm acting in the capacity of an underwriter. Underwriters provide several services, including help with correctly assessing the value of shares.
IPO év a Health Care szektor a NASDAQ-on cégekben a Pulse Biosciences Inc -hoz képest
Mit csinál Pulse Biosciences Inc?
pulse biosciences, inc. is a clinical stage electroceutical, an electrical energy based therapeutic, company pursuing commercial applications of its proprietary nano-pulse stimulation (nps) technology. nps is a non-thermal, drug-free energy-based technology that can stimulate unique behaviors in cells by applying ultra-short nanosecond (billionths of a second) electrical pulses that affect the cell membrane and intracellular structures. these cell effects influence cell regulation functions and can lead to unique immune system responses. pulse biosciences is investigating a variety of applications for its nps technology that exploits its unique biologic effect, including immuno-oncology and dermatology. pulse biosciences, inc. (plse, nasdaq) corporate headquarters is located in hayward, ca. ~ our mission ~ to build a viable company that designs, produces, and commercializes nano-pulse technology to improve and extend the lives of patients to solve the needs of patients, physicians, and
ipo év -hoz hasonló cégek Pulse Biosciences Inc
- The Toronto-Dominion Bank PFD SER 9 3.7% nak IPO év 2015 van
- Fura Gems nak IPO év 2015 van
- Hostess Brands nak IPO év 2015 van
- Nabriva Therapeutics Plc nak IPO év 2015 van
- REF nak IPO év 2015 van
- H-Source nak IPO év 2015 van
- Pulse Biosciences Inc nak IPO év 2016 van
- American Pacific Borates nak IPO év 2017 van
- Razer nak IPO év 2017 van
- DEAG Deutsche Entertainment Aktiengesellschaft nak IPO év 2017 van
- Hamilton Beach Brands Co nak IPO év 2017 van
- Artelo Biosciences nak IPO év 2017 van
- VARTA AG nak IPO év 2017 van